| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ... Science 350 (6263), 972-978, 2015 | 457 | 2015 |
| A new correlation‐based fuzzy logic clustering algorithm for FMRI X Golay, S Kollias, G Stoll, D Meier, A Valavanis, P Boesiger Magnetic resonance in medicine 40 (2), 249-260, 1998 | 368 | 1998 |
| Molecular dynamics simulations of the 136 unique tetranucleotide sequences of DNA oligonucleotides. I. Research design and results on d (CpG) steps DL Beveridge, G Barreiro, KS Byun, DA Case, TE Cheatham, SB Dixit, ... Biophysical journal 87 (6), 3799-3813, 2004 | 327 | 2004 |
| Calculation of long-distance effects in exclusive weak radiative decays of B-mesons A Khodjamirian, G Stoll, D Wyler Physics Letters B 358 (1-2), 129-138, 1995 | 226 | 1995 |
| Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ... Cell research 29 (10), 846-861, 2019 | 220 | 2019 |
| Oxidative phosphorylation as a potential therapeutic target for cancer therapy V Sica, JM Bravo‐San Pedro, G Stoll, G Kroemer International journal of cancer 146 (1), 10-17, 2020 | 179 | 2020 |
| QCD estimate of the long-distance effect in B→ K∗ γ A Khodjamirian, R Rückl, G Stoll, D Wyler Physics Letters B 402 (1-2), 167-177, 1997 | 168 | 1997 |
| CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy Y Ma, SR Mattarollo, S Adjemian, H Yang, L Aymeric, D Hannani, ... Cancer research 74 (2), 436-445, 2014 | 141 | 2014 |
| MaBoSS 2.0: an environment for stochastic Boolean modeling G Stoll, B Caron, E Viara, A Dugourd, A Zinovyev, A Naldi, G Kroemer, ... Bioinformatics 33 (14), 2226-2228, 2017 | 138 | 2017 |
| Continuous time Boolean modeling for biological signaling: application of Gillespie algorithm G Stoll, E Viara, E Barillot, L Calzone BMC systems biology 6, 1-18, 2012 | 135 | 2012 |
| Pro-necrotic molecules impact local immunosurveillance in human breast cancer G Stoll, Y Ma, H Yang, O Kepp, L Zitvogel, G Kroemer Oncoimmunology 6 (4), e1299302, 2017 | 130 | 2017 |
| PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling G Letort, A Montagud, G Stoll, R Heiland, E Barillot, P Macklin, A Zinovyev, ... Bioinformatics 35 (7), 1188-1196, 2019 | 120 | 2019 |
| Immunogenic stress and death of cancer cells: contribution of antigenicity vs adjuvanticity to immunosurveillance N Bloy, P Garcia, CM Laumont, JM Pitt, A Sistigu, G Stoll, T Yamazaki, ... Immunological reviews 280 (1), 165-174, 2017 | 104 | 2017 |
| The CoLoMoTo interactive notebook: accessible and reproducible computational analyses for qualitative biological networks A Naldi, C Hernandez, N Levy, G Stoll, PT Monteiro, C Chaouiya, ... Frontiers in physiology 9, 680, 2018 | 102 | 2018 |
| A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR A Tosco, F De Gregorio, S Esposito, D De Stefano, I Sana, E Ferrari, ... Cell Death & Differentiation 23 (8), 1380-1393, 2016 | 98 | 2016 |
| Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer A Buqué, N Bloy, M Perez-Lanzón, K Iribarren, J Humeau, JG Pol, ... Nature Communications 11 (1), 3819, 2020 | 97 | 2020 |
| Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy G Stoll, D Enot, B Mlecnik, J Galon, L Zitvogel, G Kroemer Oncoimmunology 3 (3), e27884, 2014 | 91 | 2014 |
| On the parameterization of rigid base and basepair models of DNA from molecular dynamics simulations F Lankaš, O Gonzalez, LM Heffler, G Stoll, M Moakher, JH Maddocks Physical Chemistry Chemical Physics 11 (45), 10565-10588, 2009 | 90 | 2009 |
| AIF-regulated oxidative phosphorylation supports lung cancer development S Rao, L Mondragón, B Pranjic, T Hanada, G Stoll, T Köcher, P Zhang, ... Cell research 29 (7), 579-591, 2019 | 85 | 2019 |
| A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice S Lévesque, J Le Naour, F Pietrocola, J Paillet, M Kremer, F Castoldi, ... Oncoimmunology 8 (11), e1657375, 2019 | 83 | 2019 |
